Risk-On Biotech Burst as LPTX Rockets 334%
By ATTN Desk · Editorial oversight: Sean Han
Daily Market Recap: November 12, 2025
Introduction
On November 12, 2025, small-cap and biotech names led a pronounced rally across U.S. equities, with several tickers more than doubling in share price and logging outsized volumes. Clinical-stage and speculative plays dominated headline movers, while moderate gains in specialty retail and industrial segments provided balance. Below is a snapshot of today’s key performers, followed by an analysis of overarching patterns and notable outliers.
Today’s Table
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| FMFC | $0.45 | $0.6484 | 13,786,316 | 44.91% |
| VCIG | $1.39 | $1.6600 | 12,064,708 | 19.86% |
| SLRX | $0.76 | $1.1700 | 34,028,967 | 54.46% |
| LPTX | $0.47 | $2.0500 | 498,195,822 | 334.19% |
| ONON | $37.96 | $41.5200 | 29,767,065 | 9.41% |
| NTWK | $2.41 | $2.9600 | 338,320 | 22.71% |
| FTCI | $8.61 | $11.0900 | 3,247,784 | 28.81% |
| PAL | $7.21 | $8.5400 | 842,291 | 18.40% |
| MH | $12.58 | $14.1100 | 1,076,925 | 12.18% |
| SPRU | $3.03 | $4.7400 | 5,052,832 | 56.46% |
| CMND | $0.18 | $0.3109 | 20,118,057 | 69.83% |
| SOC | $5.33 | $6.3950 | 4,839,599 | 19.90% |
| MSGM | $3.07 | $5.0201 | 3,808,119 | 63.72% |
| SI | $13.04 | $14.9900 | 306,304 | 14.94% |
| NRGV | $2.58 | $3.4400 | 3,249,570 | 33.44% |
| MAGH | $1.38 | $1.9400 | 693,677 | 40.14% |
ATTN Price reflects the approximate price at the time this article was drafted, derived from today’s percent change.
Biotech Rally by Tobias
Market Analysis
Today’s session was defined by aggressive buying in highly speculative and clinical-stage biotech stocks. Leap Therapeutics (LPTX) led the pack with an extraordinary 334% gain, fueled by news of a $58.9 million PIPE and favorable Phase 2 trial data. Salarius (SLRX) and Spruce Power (SPRU) also outperformed, advancing 54% and 56% respectively, as investors sought exposure to positive financing developments and strategic deal announcements.
Volume patterns reinforced the speculative tilt: LPTX traded nearly half a billion shares, dwarfing its typical daily flow, while SLRX and CMND each surpassed 20 million shares. MotorSport Games (MSGM) soared 63.7% on heavy volume after reporting strong Q3 results and a strategic investment.
Outside biotech, network-security name NTWK climbed 22.7% on renewed M&A chatter, and FTCI rose 28.8% amid a favorable earnings surprise. Online retailer ONON delivered a more modest 9.4% gain but maintained one of the day’s highest turnover levels with 29.8 million shares.
In contrast, more established large-caps saw limited movement, suggesting a risk-on environment primarily concentrated in micro- and small-cap segments. The breadth of today’s winners underscores persistent retail demand for high-beta names, particularly those with near-term catalysts such as financing, trial readouts, or strategic partnerships.
Highlights of Significant Moves
- LPTX (+334%): Closed a $58.9 million PIPE and reported positive Phase 2 sirexatamab data. Volume: 498 million shares.
- CMND (+69.83%): Gained after filing a $10 million convertible note program and securing expanded IP estate.
- MSGM (+63.72%): Surged on strong Q3 metrics and a $2.5 million capital injection from Pimax.
- SPRU (+56.46%): Announced strategic battery‐storage deals following an 8-K filing, driving share interest.
- SLRX (+54.46%): Filed a $6 million equity offering to back its merger with Decoy Therapeutics.
TL;DR
- Biotech and small-cap stocks led a broad risk-on rally on November 12, 2025.
- Leap Therapeutics (LPTX) jumped 334% on financing and trial news; record 498 M shares traded.
- Salarius (SLRX), Spruce Power (SPRU), CMND and MSGM each gained 50–70% on various financing and strategic catalysts.
- Moderate gains in network security (NTWK), financial tech (FTCI) and specialty retail (ONON) round out today’s winners.
- Heavy volumes concentrated in high-beta names reflect continued retail appetite for speculative plays.